Ampio Pharmaceuticals
AMPE
#10613
Rank
NZ$0.01 M
Marketcap
NZ$0.009001
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Ampio Pharmaceuticals (AMPE)

Revenue in 2023 (TTM): N/A

a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ampio Pharmaceuticals from 2009 to 2023

Annual revenue

Year Revenue Change
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A-100%
2015 NZ$0.68 M599.54%
2014 NZ$0.09 M61.07%
2013 NZ$0.06 M0.11%
2012 NZ$0.06 M152.99%
2011 NZ$0.02 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
NZ$0.37 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$159.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.17 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
NZ$0.48 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$75.89 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$24.66 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$108.68 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA